Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Base de datos
País/Región como asunto
Tipo del documento
Revista
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Nutr J ; 15: 19, 2016 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-26920136

RESUMEN

BACKGROUND: Nutrients such as docosahexaenoic acid (DHA), prebiotics and ß-glucan have been associated with reduced incidence of respiratory illnesses and allergic manifestations (AM). Our objective was to assess if consumption of a cow's milk-based beverage with these and other nutrients supports respiratory, gastrointestinal, and skin health in otherwise well-nourished, healthy children. METHODS: In this double-blind, randomized, controlled trial, healthy children (1-4 years of age) from two daycare centers in Brazil were fed three servings/day of a cow's milk-based beverage (CMBB; n = 125) containing DHA, the prebiotics polydextrose (PDX) and galactooligosaccharides (GOS), ß-glucan, and other key nutrients, or a control cow's milk-based beverage (control; n = 131) for up to 28 weeks. Occurrence of respiratory infections, diarrheal disease and AM was assessed by study pediatricians and the number of episodes were analyzed with the Cochran-Mantel-Haenszel test and the Andersen-Gill model. RESULTS: The CMBB group had fewer episodes of AM, which included allergic rhinitis or conjunctivitis, wheezing, allergic cough, eczema and urticaria, compared to the control group (p = 0.021). The hazard ratio for increased number of episodes of AM was lower in the CMBB group compared to control (HR, 0.64; 95 % CI 0.47-0.89; p = 0.007). There was no difference in the incidence of respiratory infections and diarrheal disease between groups. CONCLUSION: A cow's milk-based beverage containing DHA, PDX/GOS, and yeast ß-glucan, and supplemented with micronutrients, including zinc, vitamin A and iron, when consumed 3 times/day for 28 weeks by healthy 1- to 4-year-old children was associated with fewer episodes of allergic manifestations in the skin and the respiratory tract. TRIAL REGISTRATION: registration number: NCT01431469.


Asunto(s)
Bebidas , Diarrea/epidemiología , Hipersensibilidad/epidemiología , Leche , Infecciones del Sistema Respiratorio/epidemiología , Animales , Biomarcadores/sangre , Brasil , Preescolar , Suplementos Dietéticos , Ácidos Docosahexaenoicos/administración & dosificación , Ácidos Docosahexaenoicos/análisis , Método Doble Ciego , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Lactante , Interleucina-10/sangre , Masculino , Micronutrientes/administración & dosificación , Prebióticos/administración & dosificación , Estudios Prospectivos , Factores Socioeconómicos , Factor de Crecimiento Transformador beta1/sangre , Resultado del Tratamiento , Trisacáridos/administración & dosificación , Trisacáridos/análisis , beta-Glucanos/administración & dosificación , beta-Glucanos/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA